Eisai's anti-Insomnia drug Dayvigo (Lemborexant) approved in Hong Kong

New Drug Applications |  News | 0 Comment | 01 Mar, 2021

Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-hou...Read more

Eisai launches Parkinson's disease treatment Equfina in South Korea

New Drug Applications |  News | 1 Comment | 02 Feb, 2021

Eisai Co., Ltd. has announced that Eisai Korea Inc., (Eisai's subsidiary in South Korea) has launched the Parkinson's di...Read more

Korean firms repurpose FDA-approved drug for rheumatoid arthritis treatment

New Drug Applications |  News | 0 Comment | 11 Jan, 2021

Standigm Inc, an artificial intelligence (AI)-based drug discovery company and SK Chemicals Co, Ltd, a life science and ...Read more

Chugai’s Enspryng becomes first approved medicine for NMOSD in Taiwan

New Drug Applications |  News | 0 Comment | 11 Dec, 2020

Chugai Pharmaceutical Co., Ltd. announced that Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Chugai, obta...Read more

AstraZeneca's Forxiga approved in Japan for chronic heart failure

New Drug Applications |  News | 0 Comment | 02 Dec, 2020

AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chro...Read more

Gilead, Eisai launch rheumatoid arthritis drug in Japan

New Drug Applications |  News | 0 Comment | 19 Nov, 2020

Gilead Sciences K.K. (Head office: Chiyoda-ku, Tokyo; President and Representative Director: Luc Hermans) and Eisai Co.,...Read more

Enhancing Survival of HCC Patients in The New Era - A Multi-disciplinary Team Approach

New Drug Applications |  Company results | 4 Comment | 13 Nov, 2020

Singapore's Health Sciences Authority (HSA) recently approved an immunotherapy regimen (Tecentriq + Avastin) t...Read more

Novel drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Au, NZ, SEA

New Drug Applications |  News | 0 Comment | 06 Nov, 2020

A NEW therapy to treat advanced gastrointestinal stromal tumours (GIST) will be available to patients in Australia,...Read more

Flu antiviral TG-1000 receives FDA approval in Taiwan

New Drug Applications |  News | 0 Comment | 02 Nov, 2020

TaiGen Biotechnology Company, Limited (TaiGen) in Taiwan has announced that U.S. Food and Drug Administration (FDA) has ...Read more

Korea's Biortus facilitates drug development through its MicroED service

New Drug Applications |  News | 0 Comment | 26 Oct, 2020

Microcrystal electron diffraction (MicroED) is a new crystal structure determination technique for small molecules. It o...Read more

Fujifilm includes additional indication for COVID-19 drug

New Drug Applications |  News | 0 Comment | 19 Oct, 2020

Japanese firm FUJIFILM Toyama Chemical Co., Ltd. has announced that the company filed an Application for Partial Changes...Read more

India curbs Remdesivir price to make COVID-19 treatment more affordable

New Drug Applications |  News | 0 Comment | 16 Oct, 2020

The Indian state, Maharashtra has become the first to fix the price of remdesivir at INR2,360 (US$32.17), which is 16% m...Read more

Pediatric indication for partial-onset seizures accepted in China

New Drug Applications |  News | 0 Comment | 16 Oct, 2020

Eisai Co., Ltd. on 16 Oct 2020 announced that the supplementary new drug applications for its in-house discovered and de...Read more